MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

02 May 2024 Evaluate
The company witnessed a 14.22% growth in the revenue at Rs. 1638.17 millions for the quarter ended March 2024 as compared to Rs. 1434.19 millions during the year-ago period.The Net Loss for the quarter ended March 2024 is Rs. -114.61 millions as compared to Net Profit of Rs. 61.05 millions of corresponding quarter ended March 2023Operating profit surged to 336.13 millions from the corresponding previous quarter of 173.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1638.17 1434.19 14.22 6054.60 5983.40 1.19 6054.60 5983.40 1.19
Other Income 84.64 64.79 30.64 335.01 507.66 -34.01 335.01 507.66 -34.01
PBIDT 336.13 173.90 93.29 1406.68 1409.21 -0.18 1406.68 1409.21 -0.18
Interest 15.31 49.73 -69.21 58.06 100.56 -42.26 58.06 100.56 -42.26
PBDT -90.04 124.17 -172.51 937.76 1308.65 -28.34 937.76 1308.65 -28.34
Depreciation 62.29 39.74 56.74 235.19 151.73 55.01 235.19 151.73 55.01
PBT -152.33 84.43 -280.42 702.57 1156.92 -39.27 702.57 1156.92 -39.27
TAX -37.72 23.38 -261.33 196.13 302.14 -35.09 196.13 302.14 -35.09
Deferred Tax -97.62 -24.68 295.54 -75.49 -42.10 79.31 -75.49 -42.10 79.31
PAT -114.61 61.05 -287.73 506.44 854.78 -40.75 506.44 854.78 -40.75
Equity 104.69 104.15 0.52 104.69 104.15 0.52 104.69 104.15 0.52
PBIDTM(%) 20.52 12.13 69.22 23.23 23.55 -1.35 23.23 23.55 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..